Vivani Medical, Inc. (NASDAQ:VANI – Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 589,100 shares, a decrease of 32.4% from the March 31st total of 871,100 shares. Currently, 2.0% of the company’s stock are sold short. Based on an average daily trading volume, of 3,010,000 shares, the days-to-cover ratio is presently 0.2 days.
Vivani Medical Stock Down 3.8 %
Shares of NASDAQ VANI opened at $1.63 on Monday. The stock’s 50 day moving average price is $1.93 and its two-hundred day moving average price is $1.33. Vivani Medical has a 52-week low of $0.84 and a 52-week high of $7.80. The stock has a market capitalization of $89.62 million, a P/E ratio of -3.26 and a beta of 3.26.
Vivani Medical (NASDAQ:VANI – Get Free Report) last announced its quarterly earnings data on Tuesday, March 26th. The company reported ($0.12) earnings per share (EPS) for the quarter.
About Vivani Medical
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
- Five stocks we like better than Vivani Medical
- How to Calculate Inflation Rate
- Snap Crackles and Pops on Surprise Profit and Raised Guidance
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- MarketBeat Week in Review – 4/22 – 4/26
- Stock Splits, Do They Really Impact Investors?
- 3 Stocks Leading the U.S. Agriculture Comeback
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
